Skip to main content
logo
Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
62.90
0.00 (0.00%)
Sep 2, 2026, 5:29 PM CET

STO:IBT.B Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Revenue
--00.080.01-
Revenue
--00.080.01-
Revenue Growth
---94.80%541.67%--
Gross Profit
--00.080.01-
Selling, General & Admin
21.6120.1519.313.511.021.12
Research & Development
63.3748.85126.05121.1864.843.56
Operating Expenses
84.9869145.35134.6965.8244.67
Operating Income
-84.98-69-145.34-134.62-65.81-44.67
Interest Expense
-----0.29-0.41
Interest & Investment Income
3.063.838.4411.550.65-
Other Non Operating Income (Expenses)
-----0.09
Pretax Income
-81.92-65.17-136.91-123.07-65.45-44.99
Net Income
-81.92-65.17-136.91-123.07-65.45-44.99
Net Income to Common
-81.92-65.17-136.91-123.07-65.45-44.99
Net Income Growth
------
Shares Outstanding (Basic)
131313121111
Shares Outstanding (Diluted)
131313121111
Shares Change
--8.95%10.14%--
EPS (Basic)
-6.08-4.84-10.16-9.95-5.83-4.01
EPS (Diluted)
-6.08-4.84-10.16-9.95-5.83-4.01
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-64.07-72.34-113.13-101.22-85.8-55.62
Free Cash Flow Per Share
-4.76-5.37-8.40-8.19-7.64-4.96
Gross Margin
--100.00%100.00%100.00%-
Operating Margin
---3633575.00%-174827.27%-548400.00%-
Profit Margin
---3422625.00%-159828.57%-545425.00%-
Free Cash Flow Margin
---2828325.00%-131453.25%-714958.33%-
EBIT
-84.98-69-145.34-134.62-65.81-44.67